Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M651Revenue $M2.8Net Margin (%)-4,395.7Altman Z-Score-0.3
Enterprise Value $M487EPS $-1.0Operating Margin %-4,403.0Piotroski F-Score5
P/E(ttm)--Beneish M-Score-5.4Pre-tax Margin (%)-4,395.7Higher ROA y-yN
Price/Book7.110-y EBITDA Growth Rate %-13.2Quick Ratio5.8Cash flow > EarningsY
Price/Sales2205-y EBITDA Growth Rate %-0.1Current Ratio5.8Lower Leverage y-yY
Price/Free Cash Flow30.0y-y EBITDA Growth Rate %--ROA % (ttm)-115.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-153.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M131ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ZIOP

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ZIOPJoel Greenblatt 2015-06-30 Sold Out -0.01%$8.81 - $12.5
($10.36)
$ 5.10-51%Sold Out0
ZIOPJoel Greenblatt 2015-03-31 Buy 0.01%$4.96 - $14
($9.88)
$ 5.10-48%New holding109,080
ZIOPFirst Eagle Investment 2013-06-30 Sold Out $1.52 - $2.621
($1.85)
$ 5.10176%Sold Out0
ZIOPFirst Eagle Investment 2013-03-31 Buy $1.72 - $5.71
($4.42)
$ 5.1015%New holding200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ZIOP is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


ZIOP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BELBEL CAESAR JCOO, CLO, and Secretary 2015-11-19Sell153,333$12.84-60.28view
LEBEL FRANCOISExecutive Vice President R&D 2015-06-09Sell50,000$10.12-49.6view
BRENNAN MURRAYDirector 2015-06-04Sell40,000$9.7-47.42view
Lafond Kevin GVice Pres., Treasurer, & CAO 2015-06-03Sell57,500$9.65-47.15view
KIRK RANDAL JDirector, 10% Owner 2015-02-09Buy1,440,000$8.75-41.71view
KIRK RANDAL JDirector, 10% Owner 2013-10-29Buy2,857,143$3.545.71view
KIRK RANDAL JDirector, 10% Owner 2012-01-20Buy1,923,075$5.2-1.92view
KIRK RANDAL JDirector, 10% Owner 2011-08-23Buy38,294$4.992.2view
KIRK RANDAL JDirector, 10% Owner 2011-08-22Buy461,646$4.923.66view
Fowler WycheDirector 2011-08-10Buy5,000$5.19-1.73view

Quarterly/Annual Reports about ZIOP:

    News about ZIOP:

    Articles On GuruFocus.com
    Intrexon Corp is expanding his business Jun 25 2015 
    Hayman Advisors Update - Second Quarter Sells and Company Results Aug 26 2013 
    Bass’ New Buy – ZIOPHARM Oncology Inc. May 16 2013 
    The Far-Off Four, 52-week Lows Held by Gurus May 11 2013 

    More From Other Websites
    ZIOPHARM to Present at the 18th Annual BIO CEO & Investor Conference Feb 02 2016
    Pre-Market Pulse on Biotechnology Stocks -- ZIOPHARM Oncology, BioMarin Pharma, PTC Therapeutics,... Feb 01 2016
    Lakewood Capital Discloses Short In Pra Group Jan 30 2016
    Here’s Why Mobileye, Fitbit, & More are in the Red Today Jan 14 2016
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 11 2016
    ZIOPHARM Announces Sleeping Beauty Non-Viral Gene Transfer Technology Featured in Nature Medicine Jan 11 2016
    ZIOPHARM Announces Sleeping Beauty Non-Viral Gene Transfer Technology Featured in Nature Medicine Jan 11 2016
    ZIOPHARM to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 06 2016
    ZIOPHARM to Present at the 34th Annual J.P. Morgan Healthcare Conference Jan 06 2016
    ​One of the coolest ideas ever to treat cancer is being developed right in Charlestown Dec 28 2015
    Why You Shouldn't Bet Against ZIOPHARM Oncology (ZIOP) Stock Dec 21 2015
    EXCLUSIVE With Ziopharm CEO: Here's Why Our Genetic Programming Is Different From Competitors Dec 18 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Dec 16 2015
    Hedge Funds Are Selling ZIOPHARM Oncology Inc. (ZIOP) Dec 11 2015
    ZIOPHARM to Host Corporate Update and 2016 Outlook Conference Call on Wednesday, December 16, 2015... Dec 11 2015
    ZIOPHARM Announces Presentation of Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With... Dec 10 2015
    ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Dec 10 2015
    ZIOPHARM Announces Presentation of Phase 1b/2 Study of Ad-RTS-hIL-12 Gene Therapy in Patients With... Dec 10 2015
    Equity Price Movement at a Glance - Research on Express, ZIOPHARM Oncology, Ascena Retail Group and... Dec 09 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK